Hindustan Syringes & Medical Devices scaling up manufacturing of auto-disable syringes to assist in COVID-19 vaccination


New Delhi, August 25

Hindustan Syringes and Medical Devices (HMD) on Tuesday stated it was scaling up the manufacturing of auto-disable (AD) immunisation syringes to at least one billion items from the current annual capability of 700 million items to assist in COVID-19 vaccination.

“We have received orders from United Nations Children’s Fund (UNICEF) to increase our supply of immunisation AD syringes to the organisation to around 300 million to build up a stockpile of around 140 million syringes for COVID-19 by the end of the year,” HMD Managing Director Rajiv Nath stated in a press release.

Auto-disable syringes can’t be re-used.

“Should the (Indian) government need 100 million auto-disable syringes for COVID-19 vaccines by the end of this year, we can easily offer them to lift the outstanding orders placed with us,” Nath stated.

“The company has nearly 50 million syringes in stock that the government has not lifted timely as standard immunisation injection campaigns had been suspended due to COVID-19,” he added.

“As India gets ready for COVID-19 vaccine, the government should be well equipped with a secured stock of syringes in advance to administer a vaccine when it is approved and ready,” the medical units maker stated. PTI



Be the first to comment on "Hindustan Syringes & Medical Devices scaling up manufacturing of auto-disable syringes to assist in COVID-19 vaccination"

Leave a comment

Your email address will not be published.


*


%d bloggers like this: